Evidence indicates that the prevalence of olfactory dysfunction in COVID-19 patients is 48.85%.
Literature Reviews » COVID19
Significant aerosol levels were generated during cadaveric simulation of mastoidectomy, and aerosol spikes were appreciated during cochlear implantation in live patients.
Is office laryngoscopy an aerosol-generating procedure (AGP), and how can aerosolizing potentials in invasive otolaryngological interventions be critically assessed?
A look at the burden of depressed mood and anxiety in COVID-19 and its associated disease characteristics.
Understanding temporal dynamics of COVID-19 patient symptoms could provide fine-grained resolution to guide clinical decision-making.